Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

This week marks the beginning of the prestigious Royal Society Summer Science Exhibition, and two groups from the Medical Sciences Division are there to engage visitors with their research.

The 'Designer Malaria Vaccines' team at the exhibition. Image courtesy of Matt Higgins.  

The Royal Society Summer Science Exhibition is one of the UK's most prestigious science festivals, offering a packed programme of events and more than twenty exhibits of hands on science and technology. This year two groups from the Medical Sciences Division are represented at the Exhibition, exploring the topics of malaria vaccines and antibiotic resistance. 

Scientists from the Department of Biochemistry and the Jenner Institute (Nuffield Department of Clinical Medicine) have collaborated on the 'Designer Malaria Vaccines' exhibit, which explores how structural biology is raising hopes for a vaccine against this killer parasite. Visitors to the exhibit will be able to explore this research through a number of different activities, including digital games and hands on models. An interactive map game will demonstrate the effect of different interventions on malaria prevalence on a mythical island, with players able to spend a budget on bed nets, vaccine or drugs, and maximise the effect of their vaccine to make it truly effective. Visitors can also play play a game in which they act as the immune system, attempting to detect the conserved elements on a variable parasite. Try out the games.

Medical Sciences at Royal Society Summer Science Exhibition 2018

Sequence VR: Virtual Reality Microbes and Bacterial DNA. Image and technology courtesy of MMM, Anna Dumitriu and Alex May Arts.

Researchers from the Modernising Medical Microbiology Group (Nuffield Department of Clinical Medicine) will also be exhibiting 'Resistance is Futile,' a stand about the rise of superbugs, at the Royal Society Summer Science Exhibition. This group is also using interactive games and innovative virtual reality to explore their research, which aims to use cutting-edge technologies like DNA sequencing, and large database analysis, to understand how and why these bacteria are evolving, how we can prevent this drug-resistance from spreading, and how to improve the treatment of patients with drug-resistant infections.

Matt Higgins, Professor of Molecular Parasitology in the Department of Biochemistry and lead for the Designer Malaria Vaccines exhibit, commented: “We are really excited by the opportunity that the Royal Society Summer Science Exhibition brings to talk to many people about our design of malaria vaccines. With a child dying of malaria every couple of minutes, we urgently need such a vaccine and we hope that this exhibition will allow us to highlight this urgent need, as well as showing the advances that we are making towards this goal. We also hope that many who can’t make the exhibition in person will be able to watch our animation and play our games online.”

 

Royal Society 1.jpg Royal Society 3.jpg

Researchers from the 'Resistance is Futile' and 'Designer Malaria Vaccines' exhibits

Similar stories

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

Medical Sciences Division receives REF 2021 results

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.